In 1987, three local researchers gathered in an Encinitas garage with an idea that, 26 years later, is worth $13.6 billion. The garage belonged to Lyle Turner, who got together with partners Joe ...
From a solo flight around the world in his single-engine plane to starting a foundation that protects endangered coral reefs, Lyle Turner has seldom sat still in the decade since he retired from ...
Invitrogen Corp., a maker of chemical kits used to analyze and clone genes, agreed to buy BioReliance Corp. for $430 million to expand its production capabilities for biotechnology customers.
Invitrogen (www.invitrogen.com), supplier of reagents and tools for gene and protein research for 20 years, is expanding its product lines and moving toward cell biology. In the past few years, ...
Aga2-fusion protein binding to yeast cell by Aga1. Image provided by Invitrogen. Phage display systems, reviewed in a recent issue of The Scientist, 1 have proven enormously useful for the detection ...
Accurate and efficient data analysis of protein targets is an integral part of the gel and western blot imaging workflow. The Invitrogen iBright Analysis Software is an optimized software application ...
CellzDirect a Market Leader in Hepatocyte-Based Primary Cell Products and Services CARLSBAD, Calif. -- Invitrogen Corporation, a provider of essential life science technologies for research, ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced the successful completion of their merger transaction. The new company ...
Invitrogen's deal to sell its pharmaceutical services division, BioReliance, came at a hefty discount. Less than three years after paying $500 million for the unit, the company announced yesterday ...
Invitrogen Corporation has announced the acquisitions of Quantum Dot Corporation and the BioPixels® business unit of BioCrystal, Ltd. and the early closing of the Biosource International, Inc.
NEW YORK/BOSTON (Reuters) - Invitrogen Corp plans to buy Applied Biosystems Inc for $6.7 billion to form a top provider of research tools for the life sciences industry, the companies said on Thursday ...